SpliceBio raised $135 million in a Series B round led by EQT Life Sciences and Sanofi Ventures, with support from major biotech investors. The funding will...
CNIC researchers have developed a promising gene therapy for ARVC5, a lethal genetic heart disease. By delivering a healthy TMEM43 gene via AAV vectors, they improved...
Biointaxis has received more than €2 million from the Center for Industrial Technological Development (Cdti), a public business entity whose objective is to promote innovation and...